BACKGROUND Protein cancer biomarkers serve multiple clinical purposes, both early and
late, during disease progression. The search for new and better biomarkers has become an …

The development of biomarkers for prostate cancer screening, detection, and
prognostication has revolutionized the management of this disease. Prostate-specific …

Disease biomarkers are used widely in medicine. But very few biomarkers are useful for
cancer diagnosis and monitoring. Over the past 15 years, major investments have been …

The detection limit is one of the most important performance parameters for bioanalytical
techniques. Here we present a generic method to estimate the detection limit of …

The aim of this work was to investigate volatile organic compounds (VOCs) emanating from
urine samples to determine whether they can be used to classify samples into those from …

Background: Early detection of prostate cancer (CaP), the most prevalent cancer and the
second-leading cause of death in men, has proved difficult, and current detection methods …

Many aspects of prostate cancer diagnosis and treatment could be greatly advanced with
new, effective biomarkers. Prostate-specific antigen (PSA) has multiple weaknesses as a …

Purpose: In prostate cancer cases the early diagnosis of tumors carrying a high risk of
progression is of the utmost importance. There is an urgent clinical need to avoid …

In order to successfully cure patients with prostate cancer (PCa), it is important to detect the
disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they …

Biomarkers are vital to detect diseases in various clinical stages. A variety of cancer serum
biomarkers are already known, while for more accurate cancer-type detection, there …